Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B L Shulkin

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Radiology|February 1, 1995
Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studiesB L Shulkin, D S Mitchell, D R Ungar, et al.
Journal of Nuclear Biology and Medicine (Turin, Italy : 1991)|October 1, 1991
Long-term results of [131I]metaiodobenzylguanidine treatment of refractory advanced neuroblastomaR J Hutchinson, J C Sisson, J S Miser, et al.
American Journal of Clinical Oncology|June 1, 1992
131-I-metaiodobenzylguanidine treatment in patients with refractory advanced neuroblastomaR J Hutchinson, J C Sisson, B Shapiro, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1992
PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytomaB L Shulkin, D M Wieland, M Schwaiger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1986
Iodine-123-4-amino-3-iodobenzylguanidine, a new sympathoadrenal imaging agent: comparison with iodine-123 metaiodobenzylguanidineB L Shulkin, B Shapiro, M C Tobes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1996
PET hydroxyephedrine imaging of neuroblastomaB L Shulkin, D M Wieland, M E Baro, et al.
Revista Espanola De Medicina Nuclear E Imagen Molecular|January 12, 2019
<sup>68</sup>Ga-DOTATOC PET/CT in the localization of metastatic extra-adrenal paraganglioma and pheochromocytoma compared with <sup>18</sup>F-DOPA PET/CTA S Kroiss, C Uprimny, B L Shulkin, et al.
British Journal of Cancer|October 14, 2015
Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRIJ Guo, J O Glass, M B McCarville, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 1997
Specificity of radioiodinated MIBG for neural crest tumors in childhoodA Leung, B Shapiro, R Hattner, et al.
Endocrine-Related Cancer|June 11, 2005
Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytomaF M Brouwers, E F Petricoin, L Ksinantova, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Radiology|February 1, 1995
Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studiesB L Shulkin, D S Mitchell, D R Ungar, et al.
Journal of Nuclear Biology and Medicine (Turin, Italy : 1991)|October 1, 1991
Long-term results of [131I]metaiodobenzylguanidine treatment of refractory advanced neuroblastomaR J Hutchinson, J C Sisson, J S Miser, et al.
American Journal of Clinical Oncology|June 1, 1992
131-I-metaiodobenzylguanidine treatment in patients with refractory advanced neuroblastomaR J Hutchinson, J C Sisson, B Shapiro, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1992
PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytomaB L Shulkin, D M Wieland, M Schwaiger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1986
Iodine-123-4-amino-3-iodobenzylguanidine, a new sympathoadrenal imaging agent: comparison with iodine-123 metaiodobenzylguanidineB L Shulkin, B Shapiro, M C Tobes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1996
PET hydroxyephedrine imaging of neuroblastomaB L Shulkin, D M Wieland, M E Baro, et al.
Revista Espanola De Medicina Nuclear E Imagen Molecular|January 12, 2019
<sup>68</sup>Ga-DOTATOC PET/CT in the localization of metastatic extra-adrenal paraganglioma and pheochromocytoma compared with <sup>18</sup>F-DOPA PET/CTA S Kroiss, C Uprimny, B L Shulkin, et al.
British Journal of Cancer|October 14, 2015
Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRIJ Guo, J O Glass, M B McCarville, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 1997
Specificity of radioiodinated MIBG for neural crest tumors in childhoodA Leung, B Shapiro, R Hattner, et al.
Endocrine-Related Cancer|June 11, 2005
Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytomaF M Brouwers, E F Petricoin, L Ksinantova, et al.
Pageof 7